Biogen Idec Shifting Tysabri Sales Force To Avonex Detail
This article was originally published in The Pink Sheet Daily
Executive Summary
Biogen Idec will shift the focus of its Tysabri sales force to Avonex promotion following the marketing suspension of the newer multiple sclerosis agent, the company said